Technology
Causal AI Market worth $761.4 million by 2031 – Report by MarketsandMarkets™
Published
1 hour agoon
By
DELRAY BEACH, Fla., Oct. 16, 2026 /PRNewswire/ — According to MarketsandMarkets™, the global Causal AI Market is estimated at USD 158.7 million in 2026 and is projected to reach USD 761.4 million by 2031, registering a 36.8% CAGR during 2026–2031.
Browse 300 market data Tables and 50 Figures spread through 350 Pages and in-depth TOC on “Causal AI Market – Global Forecast to 2031”
Causal AI Market Size & Forecast:
Market Size Available for Years: 2021–20312025 Market Size: USD 110.7 million2026 Market Size: USD 158.7 million2031 Projected Market Size: USD 761.4 millionCAGR (2026–2031): 36.8%
Causal AI Market Trends & Insights:
Growth is being supported by demand for causal discovery, causal inference, counterfactual analysis, root-cause diagnosis, experimentation, and decision optimization across financial services, life sciences, marketing, industrial operations, and enterprise planning.Software is estimated to account for 77.8% of the Causal AI Market in 2026The decision intelligence & scenario planning segment is expected to register the fastest growth of 42.4% CAGR between 2026 and 2031The healthcare, pharma & life sciences segment is expected to be the fastest-growing segment across the forecast periodNorth America is estimated to account for the largest regional share of 37.1% in 2026
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162494083
Rising enterprise demand for AI systems that can determine why outcomes occur, estimate intervention impacts, compare alternative actions, and support decisions amid changing business conditions is driving growth. Organizations are increasingly using causal discovery, treatment-effect estimation, counterfactual analysis, root-cause diagnosis, experimentation, and decision optimization to complement conventional predictive analytics. Adoption is expanding across life sciences, financial services, marketing, industrial operations, and enterprise planning. Integrating Causal AI with generative AI, agentic AI, digital twins, and automated experimentation is further accelerating commercialization by embedding causal reasoning directly into recurring operational and strategic workflows, rather than confining it to specialist data-science projects.
Software is becoming the primary layer for operationalizing causal reasoning at enterprise scale.
Software is expected to account for the largest share of the Causal AI Market in 2026, supported by rising adoption of platforms and point solutions that combine causal discovery, inference, simulation, experimentation, and decision optimization within reusable enterprise environments. Organizations are increasingly moving away from isolated causal modeling projects toward software that can connect with existing data estates, support multiple decision workflows, and make causal analysis accessible to business users. Broad Causal AI platforms are expanding into counterfactual simulation, intervention analysis, optimization, and agentic execution, while point solutions are gaining adoption in focused areas such as life sciences, marketing measurement, IT operations, and industrial analytics. This transition toward production-grade software is strengthening recurring revenue opportunities, increasing deployment scale, and enabling causal capabilities to become part of day-to-day enterprise decision processes rather than one-time analytical engagements.
Request for Proposal: https://www.marketsandmarkets.com/requestsampleNew.asp?id=162494083
Decision Intelligence & Scenario Planning is emerging as the strongest growth avenue for action-oriented Causal AI.
Decision intelligence & scenario planning is expected to be the fastest-growing application segment during the forecast period, as organizations increasingly seek to understand the likely consequences of alternative actions before committing capital or operational resources. The segment includes business-driver analysis, what-if modeling, counterfactual simulation, intervention-impact assessment, and resource-allocation optimization. Causal AI enables enterprises to move beyond forecasting what may happen toward estimating what could happen if controllable variables such as pricing, investment, promotions, capacity, or operating policies are changed. This is expanding adoption across strategic planning, commercial decision-making, capital allocation, and operational optimization. Vendors are consequently developing simulation-led environments that allow decision-makers to compare multiple courses of action, quantify potential trade-offs, and select interventions more closely aligned with desired business outcomes under changing market and operating conditions.
North America combines vendor concentration, enterprise AI maturity, and high-value causal use cases.
North America is expected to account for the largest share of the Causal AI Market in 2026, supported by a mature enterprise AI ecosystem, strong availability of advanced analytics talent, and high adoption of data-driven decision technologies across major industries. The region has particularly strong commercial activity in pharmaceutical research, marketing measurement, enterprise decision intelligence, explainable AI, and experimentation, where causal approaches are increasingly being integrated into production workflows. North America also hosts several prominent vendors, including Aitia, Alembic, LiftLab, Measured, Lifesight, and Howso, covering areas such as life sciences digital twins, enterprise causal intelligence, incrementality measurement, and understandable AI. High technology spending among pharmaceutical, financial services, retail, consumer goods, and technology companies, combined with an established ecosystem of data providers, cloud platforms, consulting firms, and AI developers, is expected to sustain the region’s market leadership.
Request Pricing: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=162494083
Top Companies in Causal AI Market:
The Top Companies in Causal AI Market are causaLens (UK), Aitia (US), Alembic (US), LiftLab (US), Prophet (Australia), Measured (US), Causaly (UK), Lifesight (US), Causify (US), and Howso (US). These vendors illustrate the different commercialization models emerging across the market, ranging from horizontal Causal AI platforms and enterprise decision-intelligence systems to life sciences digital twins, scientific intelligence, marketing incrementality, scenario simulation, and explainable AI. Competitive differentiation is increasingly determined by the ability to operationalize causal reasoning within existing enterprise workflows, integrate with data and AI environments, support domain-specific decision processes, and demonstrate measurable business outcomes. Vendors that combine proprietary causal technology with strong implementation capabilities, domain expertise, enterprise integrations, and repeatable applications are better positioned to expand contract values and move from departmental deployments toward broader enterprise adoption as the market matures.
Causal AI Market – Investment & funding +Merger & Acquisition
Investment Funding Context
Investment activity in the Causal AI Market is increasingly concentrating on vendors that can convert causal models into scalable enterprise decision systems rather than offering causal analysis as a standalone data-science capability. Capital is being directed toward real-time decision intelligence, causal simulation, domain-specific applications, and infrastructure capable of operationalizing causal reasoning at enterprise scale. In November 2025, Alembic raised USD 145 million in Series B and growth financing, led by Prysm Capital and Accenture, with participation from WndrCo, NextEquity, Silver Lake Waterman, Liquid 2 Ventures, and other investors. The financing is supporting expansion of its Causal AI research and high-performance computing infrastructure for enterprise intelligence.
Funding is also reaching smaller Causal AI specialists targeting operational decision-making. In September 2025, Causify raised an additional USD 2.2 million in seed capital to expand its enterprise causal decision-intelligence platform across financial services, energy, supply chain, and industrial applications. FireAI has similarly raised multiple early-stage rounds since 2025 to develop its causal decision-intelligence capabilities, including Causal Chain analysis, enterprise data integration, and conversational analytics. Public funding records indicate cumulative funding of more than USD 1.4 million by July 2026. These investments show a two-tier funding pattern: substantial capital is supporting the infrastructure and commercial expansion of established platforms, while smaller rounds are financing application-focused entrants seeking to embed causal reasoning into specific enterprise workflows.
Revenue Shift Context
Revenue generation in the Causal AI Market is progressively shifting from individual causal modeling projects toward recurring software platforms, decision-intelligence systems, and application-specific point solutions. The market is estimated to increase from USD 158.7 million in 2026 to USD 761.4 million by 2031, at a CAGR of 36.8%. As deployments mature, commercial value is moving beyond causal discovery and model development toward counterfactual simulation, intervention analysis, decision optimization, automated experimentation, and recurring operational workflows. This favors vendors that can integrate causal reasoning directly into existing business systems rather than require enterprises to build bespoke causal models for each use case. Two monetization models are becoming increasingly visible. Broad platform vendors are expanding revenue through enterprise-wide deployments that support multiple functions and integrate causal reasoning with agents, knowledge systems, and workflow automation. Point-solution vendors are monetizing narrower but high-value outcomes. This shift is expected to increase recurring software revenue and expand average contract values as Causal AI moves closer to production decision processes.
Mergers & Acquisitions
Direct M&A among pure-play Causal AI platform vendors remains relatively limited, reflecting the market’s early stage and the continued independence of many specialist companies. However, acquisition activity is increasing in causal measurement, incrementality, and decision intelligence, which form an important part of the Causal AI point-solution layer. Buyers are using acquisitions to add experimental measurement, counterfactual analysis, and causal performance intelligence to broader advertising, analytics, and enterprise decision platforms. The pattern indicates that larger analytics and advertising technology platforms are acquiring causal measurement capabilities to connect measurement directly with optimization and execution. Similar consolidation could emerge across other Causal AI applications as vendors seek differentiated capabilities in simulation, causal decisioning, life sciences, and operational intelligence.
CAUSAL AI MARKET: MERGERS & ACQUISITIONS, JANUARY 2025–MAY 2026
Month & Year
Deal Type
Company 1
Company 2
Description
May 2026
Acquisition
Smartly (US)
INCRMNTAL (Israel)
Smartly completed its acquisition of INCRMNTAL, adding always-on incrementality measurement and causal marketing intelligence to its creative and media optimization platform. Financial terms were not disclosed.
August 2025
Acquisition
Circana (US)
Nielsen (US)
Circana completed the acquisition of Nielsen’s Marketing Mix Modeling (MMM) business, expanding its capabilities for measuring incremental marketing impact and optimizing cross-channel investment. Financial terms were not disclosed.
March 2025
Acquisition
DoubleVerify (US)
Rockerbox (US)
DoubleVerify acquired Rockerbox to add MMM, incrementality testing, attribution, and outcome measurement to its media performance platform. The purchase price was approximately USD 82.3 million, net of cash acquired.
Company Revenue Share Details
The top five companies account for approximately 42% of the Causal AI Market in 2025. The leading group comprises causaLens, Aitia, Alembic, LiftLab, and Prophet. Their positions reflect different Causal AI commercialization models, ranging from broad causal reasoning and enterprise decision platforms to life sciences digital twins, marketing incrementality, and simulation-led decision intelligence. The top ten vendors collectively account for approximately 66% of the market. In addition to the leading five, Measured, Causaly, Lifesight, Causify, and Howso form the broader leading competitive group. Measured and Lifesight strengthen the market’s causal measurement and incrementality segment, while Causaly is concentrated on scientific intelligence and life sciences research. Causify focuses on enterprise causal decision intelligence, while Howso combines explainable AI with causal analysis, counterfactuals, and intervention optimization. The relatively high share held by the top ten indicates increasing concentration around vendors with differentiated causal technology, established enterprise deployments, domain expertise, and the ability to embed causal reasoning directly into recurring business decisions.
Browse Adjacent Markets: Artificial Intelligence (AI) Market Research Reports & Consulting
Related Market Reports:
Artificial Intelligence (AI) Market by Offering [Hardware (AI Chips, Memory, Storage), Software, Services], Technology (ML, NLP, Generative AI, Neurosymbolic AI), Business Function (Operations & Supply Chain, Sales & Marketing) – Global Forecast to 2033
Decision Intelligence Market by Type (Decision Automation, Decision Augmentation, Decision Support System), Business Function (Marketing & Sales, Finance & Accounting (Financial Planning, Cost Optimization), Operations, R&D) – Global Forecast to 2030
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/causal-ai.asp
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/causal-ai-market-worth-761-4-million-by-2031–report-by-marketsandmarkets-302911204.html
You may like
Technology
CRISPR Market worth $6.12 billion by 2031 – Exclusive Report by MarketsandMarkets™
Published
3 minutes agoon
October 16, 2026By
DELRAY BEACH, Fla., Oct. 16, 2026 /PRNewswire/ — According to MarketsandMarkets™, the CRISPR Market is projected to reach USD 6.12 billion by 2031 from USD 3.48 billion in 2026, at a CAGR of 12.0% during the forecast period.
Browse 388 market data Tables and 53 Figures spread through 319 Pages and in-depth TOC on “CRISPR Market – Global Forecast to 2031”
CRISPR Market Size & Forecast:
Market Size Available for Years: 2026–20312026 Market Size: USD 3.48 billion2031 Projected Market Size: USD 6.12 billionCAGR (2026–2031): 12.0%
CRISPR Market Trends & Insights:
North America accounted for the largest share, 49.7%, of the CRISPR market in 2025.By offering, products accounted for the largest share of 70.7% of the CRISPR market in 2025.By application, drug discovery & development accounted for the largest share of the CRISPR market in 2025.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134401204
The CRISPR market is expanding as pharmaceutical and biotechnology companies and academic & research institutes increasingly adopt gene-editing technologies to support drug discovery, functional genomics, therapeutic development, and agricultural research. CRISPR tools are widely used for gene knockout, knock-in, target identification and validation, disease modeling, cell line development, and high-throughput screening. Rising demand for precise, efficient genome editing is accelerating adoption of CRISPR kits & enzymes, libraries, gRNA solutions, and specialized screening and validation services. In addition, ongoing advances in CRISPR-Cas systems, gRNA design and optimization, base editing, prime editing, and gene delivery technologies are improving editing specificity, efficiency, and workflow scalability. The growing development of CRISPR-based therapies and wider application of gene editing across research and commercial settings are further supporting market expansion.
By offering, the products segment held the largest share of the CRISPR market in 2025.
By offering, the CRISPR market is segmented into products and services. In 2025, products accounted for the largest market share. This is mainly due to recurring demand for CRISPR kits, enzymes, libraries, guide RNAs, and other research consumables across gene-editing workflows. Pharmaceutical and biotechnology companies, as well as academic and research institutes, use these products for gene knockout, gene activation, functional genomics, target validation, and drug discovery. The growing adoption of CRISPR-based screening and increasing gene editing research further support product consumption. Continued development of advanced Cas enzymes, optimized guide RNA solutions, and ready-to-use CRISPR kits also supports the segment’s leading position.
By product type, the CRISPR kits & enzymes segment held the largest share of the CRISPR product market in 2025.
By product type, the CRISPR product market is segmented into CRISPR kits & enzymes, CRISPR libraries, and other products. In 2025, CRISPR kits & enzymes accounted for the largest market share. Their leading position is supported by their extensive use across routine gene editing, target validation, cell engineering, and functional genomics workflows. CRISPR kits provide researchers with standardized components for gene knockout, knock-in, and other genome editing experiments, while enzymes such as Cas9 and other Cas nucleases are core components of CRISPR workflows. Their broad applicability across pharmaceutical research, biotechnology R&D, and academic laboratories creates recurring demand. The availability of workflow-specific kits and improved CRISPR enzymes with enhanced editing performance further supports this segment’s dominance.
Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=134401204
By region, North America accounted for the largest share of the market in 2025.
In 2025, North America held the largest share of the CRISPR market. This is supported by strong biotechnology and pharmaceutical research activity, high investment in gene editing, and a well-established life sciences infrastructure. The US leads the region in CRISPR-based drug discovery, functional genomics, high-throughput screening, and therapeutic development. Leading CRISPR technology providers, biotechnology companies, academic research institutes, and pharmaceutical companies create strong demand for CRISPR products and services. Growing clinical development of gene-edited therapies and continued advancements in CRISPR-Cas systems, guide RNA technologies, and screening platforms further support market growth in North America.
Key Players
Leading players in the CRISPR companies include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), GenScript (US), Takara Bio (Japan), Creative Biogene (US), Fujian SunyBiotech Co., Ltd. (China), EditCo (US), Caribou Biosciences, Inc. (US), and Lonza (Switzerland), among others.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=134401204
CRISPR Market – Investment & funding +Merger & Acquisition
Investment Funding Context
The CRISPR market is seeing increasing investment and funding activity, driven by expanding gene-editing therapeutic pipelines, advances in CRISPR-Cas technologies, and the growing development of next-generation approaches such as base editing, prime editing, and epigenetic editing. Investment activity is increasingly focused on improving editing precision and delivery, advancing therapeutic candidates through clinical development, and expanding applications across genetic diseases and other therapeutic areas. For instance, in January 2025, Tune Therapeutics raised USD 175 million in Series B financing to advance its epigenetic editing platform and therapeutic pipeline. The financing highlights continued investor interest in differentiated gene-editing technologies with potential to address a broader range of diseases. This funding activity supports technology development, clinical translation, and commercialization across the CRISPR market.
Revenue Shift Context
The CRISPR market is gradually shifting revenue from conventional CRISPR-Cas9 systems and basic gene-editing reagents toward higher-growth categories such as engineered Cas nucleases, advanced CRISPR kits, high-throughput screening solutions, base editing, prime editing, and specialized gene-editing services. The global CRISPR market is projected to increase from USD 3.48 billion in 2026 to USD 6.12 billion by 2031, at a CAGR of 12.0%, with a growing share of incremental revenues expected from advanced editing platforms, customized gRNA solutions, CRISPR libraries, cell line development, and screening & validation services. Meanwhile, conventional Cas9-based products remain an important revenue base, but next-generation editing technologies and specialized services are gaining adoption across pharmaceutical & biotechnology companies and academic & research institutes.
Mergers and Acquisitions
Mergers and acquisitions in the CRISPR market are being driven by the need to strengthen gene-editing technology portfolios, gain access to proprietary CRISPR platforms, expand therapeutic development capabilities, and acquire expertise in next-generation editing and delivery technologies. Such transactions also enable companies to broaden their presence across drug discovery, functional genomics, and CRISPR-based therapeutic development.
CRISPR MARKET: MERGERS AND ACQUISITIONS, JANUARY 2023–SEPTEMBER 2026
Month & Year
Deal Type
Company 1
Company 2
Description
Deal Size
June 2025
Acquisition
Demeetra AgBio (US)
Hera BioLabs (US)
Demeetra acquired Hera BioLabs, bringing Super piggyBac licensing, development, and commercial activities under Demeetra. The acquisition expanded Demeetra’s genome-engineering portfolio and incorporated Hera’s in vitro capabilities into its internal R&D operations.
NA
July 2024
Acquisition
Agilent Technologies, Inc. (US)
BioVectra Inc. (Canada)
Agilent Technologies, Inc. (US) acquired BioVectra, Inc. (Canada), enhancing its biopharma solutions with BioVectra’s expertise in biologics and gene editing. The acquisition expanded Agilent’s drug development and manufacturing capabilities.
USD 925 Million
Company Revenue Share Details
The top four players collectively account for approximately 25-27% of the global CRISPR market, indicating a highly competitive landscape. This reflects established life sciences companies alongside specialized gene-editing technology and service providers. Key market participants include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), GenScript (US), Takara Bio (Japan), Creative Biogene (US), Fujian SunvBiotech Co., Ltd. (China), EditCo (US), Caribou Biosciences, Inc. (US), and Lonza (Switzerland). These companies compete across CRISPR kits & enzymes, libraries, gRNA solutions, cell line development, screening & validation, and other gene-editing services. Continued innovation in advanced CRISPR systems, editing optimization, high-throughput screening, and specialized services is further intensifying competition across the market.
Browse Adjacent Market: Biotechnology Market Research Reports &Consulting
See More Latest Medical Devices Reports:
Gene Editing Market by Product (Kits, Reagents, Libraries, Software), Services (gRNA Synthesis & Vector Construction), Technique (Knock-Out, Knock-In), Technology (CRISPR, ZFN, TALEN), Application (Genome Editing, Drug Discovery) – Global Forecast to 2029
Genomics Market Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) – Global Forecast to 2030
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/crispr-technology-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/crispr-technology.asp
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/crispr-market-worth-6-12-billion-by-2031—exclusive-report-by-marketsandmarkets-302911142.html
Technology
Teachers Federal Credit Union Accelerates Strategic Branch Expansion Across New York and Florida
Published
3 minutes agoon
October 16, 2026By
New locations complement the credit union’s nationwide digital capabilities while strengthening member relationships and community connection
HAUPPAUGE, N.Y., Oct. 16, 2026 /PRNewswire/ — Teachers Federal Credit Union, one of the nation’s largest credit unions with $9.9 billion in assets and over 472,000 members, is continuing to expand its branch network across New York and Florida, with new locations planned for Estero and Wesley Chapel, Florida, and Farmingville, New York.
With a national open charter and members across all 50 states, Teachers combines the convenience of digital banking with access to personalized financial guidance. As the credit union’s membership has grown nationwide, its physical footprint has evolved alongside it, with continued investment in its home state of New York and an increasing presence in Florida. Teachers is also identifying additional markets across the country where a branch can bring the credit union closer to its members and support its long-term mission of helping members build a strong financial foundation today, for a better tomorrow.
“Our growth is guided by how we can better serve our members and support their financial well-being,” said Brad Calhoun, President and CEO of Teachers Federal Credit Union. “Our digital capabilities make it possible for us to serve members wherever they are, while our branches provide opportunities to build personal relationships and offer guidance through the financial moments that matter most. As we continue to expand in New York, strengthen our presence in Florida, and enter new markets, we remain focused on giving members more convenient ways to connect with Teachers and access the personalized service, expertise, and support they value – wherever and whenever they need us.”
To help guide its branch strategy, Teachers partnered with global commercial real estate services firm JLL to conduct a market screening.
“Establishing our partnership with JLL was an important step in developing our approach to branch expansion. We wanted to understand where our members are, what markets are evolving, and where a physical presence could create the greatest opportunity for Teachers,” added Inna Sprague, Chief Experience Officer, Teachers Federal Credit Union. “We combined internal data with factors such as market growth, demographics, competition, and site characteristics of potential locations to develop a branch expansion strategy that aligned with member needs, market opportunity, and our broader growth goals.”
Teachers has steadily expanded its branch network in recent years, entering the Florida market with its first location in Tampa’s Westshore district in 2023 and building on that presence with branches in Naples in 2025 and Lake Mary, serving the greater Orlando region, in 2026. In New York, Teachers opened a new branch in Holbrook in 2025 and continues to invest in its Long Island footprint. The planned locations in Estero, Wesley Chapel, and Farmingville represent the next phase of that strategy, expanding access in markets where Teachers sees opportunities to serve both existing and future members.
As Teachers grows, its investment in the communities it serves grows with it. The credit union’s approach extends beyond opening branches to supporting organizations and causes that make a meaningful difference in the places where its members live and work. Through its annual Golf Tournament benefiting Children’s Miracle Network, Teachers has raised more than $3 million since 2023 to support children and families, including through partnerships with Cohen Children’s Medical Center in New York and Johns Hopkins All Children’s Hospital and Nicklaus Children’s Hospital in Florida. Teachers also supports the American Cancer Society through Making Strides Against Breast Cancer, serving in 2026 as Presenting Sponsor on Long Island and Eastern Long Island and Silver Sponsor in Tampa Bay and Southwest Florida.
For more information about Teachers Federal Credit Union, please visit www.teachersfcu.org
About Teachers Federal Credit Union
Teachers Federal Credit Union (Teachers) is one of the country’s largest credit unions, with $9.9 billion in assets and over 472,000 members across all 50 states. Founded in New York in 1952, Teachers is a full-service, not-for-profit financial institution with an open charter offering membership to anyone in the U.S. through its 33 full-service branches and best-in-class digital solutions. Teachers is a key supporter of the communities it serves and is proud to offer a range of member-focused products with competitive rates and low fees. What started as a smart solution for teachers is now smart for all. For more information, visit www.teachersfcu.org.
View original content to download multimedia:https://www.prnewswire.com/news-releases/teachers-federal-credit-union-accelerates-strategic-branch-expansion-across-new-york-and-florida-302911362.html
SOURCE Teachers Federal Credit Union
Technology
Renewable Energy Tax Credit Professionals to Explore Changing Energy Policy Landscape at Novogradac Conference
Published
3 minutes agoon
October 16, 2026By
Novogradac to Host 2026 Fall Renewable Energy Tax Credits Conference, Nov. 5-6 in Washington, D.C.
SAN FRANCISCO, Oct. 16, 2026 /PRNewswire/ — Clean energy professionals will gather to receive actionable, technical insights into navigating the evolving renewable energy tax credit (RETC) market at the Novogradac 2026 Fall Renewable Energy Tax Credits Conference, Nov. 5-6 at the Fairmont Washington, D.C. Georgetown.
Set at a pivotal moment for the renewable energy market and immediately after the 2026 mid-term elections, this conference will bring together attorneys, developers, investors, lenders, tax insurance providers and advisors to examine the policy, structuring and financing issues shaping RETC investments. Attendees will engage with practical, technically focused content regarding deal execution, market developments and the challenges industry professionals are facing.
Sessions at the conference will discuss recent federal developments affecting clean energy tax incentives, technical tax considerations shaping deal execution, the clean energy development landscape and how it is evolving, what is driving investor interest in certain properties, tax equity structures and more. The full conference agenda can be found here.
“This year, the RETC sector has been shaped by major changes in federal policy and guidance. It’s important to stay up to date with the current state of the market,” said Tony Grappone, a partner in Novogradac’s North Andover, Massachusetts, office and chair of the conference. “This conference offers a targeted experience centered on technical content and represents an opportunity to connect with other professionals facing similar challenges.”
The Novogradac 2026 Fall Renewable Energy Tax Credits Conference is co-hosted by Bildmore, CAC, Crux, Foley and Lardner, Monarch Private Capital, Nixon Peabody and Raymond James. Conference sponsors include Alliant, Alston & Bird, Aon, Concentro, Crowell & Moring, DLA Piper, Euclid Transactional, Foley Hoag, Foss & Company, Howden, Key State, Latham & Watkins, Lux Speed Capital, National Trust Energy Capital, Reunion, Ryan, Sugar Creek Capital and Summit Ridge Energy. Kutak Rock and Prince Lobel will be exhibitors at the conference.
Novogradac will host a pre-conference workshop Wednesday, Nov. 4. The Project Finance Primer: Fundamentals & Monetization workshop will provide insights into financing clean energy developments by using tax credits as part of the capital stack. Topics of discussion will include the state of the market, what incentives are available, various tax equity structures and hot topics such as foreign entities of concern, prevailing wage and apprenticeship, domestic content and more. Separate registration fees apply for the pre-conference workshop.
About Novogradac
Novogradac, which has been in business for more than 35 years, has grown to more than 800 employees and partners with offices in more than 25 cities. Tax, audit and consulting specialty practice areas for Novogradac include affordable housing, community development, historic rehabilitation and renewable energy. For additional information on Novogradac’s personnel and areas of expertise, visit www.novoco.com or call (415) 356-8000.
View original content:https://www.prnewswire.com/news-releases/renewable-energy-tax-credit-professionals-to-explore-changing-energy-policy-landscape-at-novogradac-conference-302910360.html
SOURCE Novogradac & Company LLP
CRISPR Market worth $6.12 billion by 2031 – Exclusive Report by MarketsandMarkets™
Teachers Federal Credit Union Accelerates Strategic Branch Expansion Across New York and Florida
Renewable Energy Tax Credit Professionals to Explore Changing Energy Policy Landscape at Novogradac Conference
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology3 days agoMesa School of Business raises ₹110 crore to expand its portfolio of programmes for the AI era
-
Technology3 days agoCresta Launches Deputy Agent: an AI Agent That Keeps Working Long After the Customer Hangs Up
-
Technology4 days agoJK Tech Names Mahesh Ramakrishnan as New Chief Technology Officer
-
Technology4 days agoPayJoy to Acquire Strategic Assets of Finia AI, Advancing AI Underwriting and Financial Product Innovation
-
Technology3 days agoIntellistake Highlights NanoAi’s Collaboration With Global Defense Helmet Leader Gentex Corporation
-
Technology4 days agoFraikin announces exclusive agreement with Asterion Industrial Partners to support its next phase of growth
-
Technology4 days agoASE Technology Holding Co., Ltd. Announces Monthly Net Revenues*
-
Technology4 days agoFlex Expands Prefabricated Modular Data Center Portfolio to Accelerate AI Factory Deployment
